C-MER Medical Holdings (03309) Announces Share Repurchase Update

Bulletin Express11-21

C-MER Medical Holdings Limited (Stock Code: 03309) released a Next Day Disclosure Return dated 21 November 2025, detailing a repurchase of 240,000 ordinary shares from the market at prices ranging between HKD 1.73 and HKD 1.75, totaling HKD 417,640. This transaction reduced the outstanding ordinary shares (excluding treasury shares) from 1,238,912,870 to 1,238,672,870, a 0.0194% decrease, and increased treasury shares from 16,648,000 to 16,888,000. The overall number of shares, including treasury shares, remains 1,255,560,870.

The repurchase was conducted under a mandate passed on 19 May 2025 authorizing the company to repurchase up to 125,556,087 shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment